Clinical study of the antiarrhythmic properties of amiodarone
Reymond, C.; Rivier, J.L.
Therapeutische Umschau. Revue Therapeutique 30(3): 223-230
1973
ISSN/ISBN: 0040-5930 PMID: 4569630 Document Number: 65829
Document emailed within 1 workday
Related Documents
Ernest, K. 1975: Pharmacology of new ethylenediamine derivatives (ROM-126, ROM-131, MK-142) with antiarrhythmic action. Part II. Antiarrhythmic properties, the influence on heart and some hemodynamic parameters Polish Journal of Pharmacology and Pharmacy 27(4): 381-398Sloskey, G.E. 1983: Amiodarone: a unique antiarrhythmic agent Clinical Pharmacy 2(4): 330-340
Pecquet-Bathellier, C.; Quevauviller, A. 1978: Comparative study of antiarrhythmic properties of quinicine versus quinidine La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 54(29-32): 953-957
Hagelüken, A.; Nürnberg, B.; Harhammer, R.; Grünbaum, L.; Schunack, W.; Seifert, R. 1995: The class IIi antiarrhythmic drug amiodarone directly activates pertussis toxin-sensitive G proteins Molecular Pharmacology 47(2): 234-240
Somani, P.; Simon, V.A.; McManus, K. 1985: Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion Canadian Journal of Cardiology 1(1): 56-65
Herrmann, G.R.; Secrest, C.R.; Vilbig, G.J.; Uint, R.A.; Herrmann, A.W. 1964: Antiarrhythmic and Antifibrillary Antazoline: A Clinical Study Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 116: 145-158
Warembourg, H.; Ducloux, G. 1976: Clinical study of injectable amiodarone in arrhythmia Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 21(Suppl 4): 908-910
Van Schepdael, J.; Solvay, H. 1970: Clinical study of amiodarone in cardiac rhythmic disorders La Presse Medicale 78(42): 1849-1850
Wanet, J.; Achten, G.; Barchewitz, G.; Mestdagh, C.; Vastesaeger, M. 1971: Amiodarone and cutaneous depostis. Clinical and histological study Annales de Dermatologie et de Syphiligraphie 98(2): 131-140
Bouffard, Y.; Berger, Y.; Delafosse, B. 1985: Acute amiodarone poisoning. Clinical and pharmacokinetic study Archives des Maladies du Coeur et des Vaisseaux 78(10): 1589-1590
Corday, E.; Enescu, V.; Vyden, J.K.; Serruya, A.; Lang, T.W.; Carvalho, M. 1971: Antiarrhythmic properties of carbamazepine Geriatrics 26(10): 78-81
Rivera-Bou, W.L.; Torres-Galarza, F.; Deynes, S. 2007: Can etomidate have antiarrhythmic properties? Boletin de la Asociacion Medica de Puerto Rico 99(4): 310-313
Eckstein, M.; Zajaczkowska, J.; Samochowiec, L. 1988: (RS), (R)(-) and (S)(+) derivatives of 2-N-arylalkylamino-1-butanol having antiarrhythmic properties Polish Journal of Pharmacology and Pharmacy 40(4): 401-411
Laskawiec, G.; Zmudziński, J.; Jamrozik-Kruk, Z. 1993: Bepridil--a new antianginal agent with antiarrhythmic properties Polski Tygodnik Lekarski 48(14-15): 330-332
Scholtysik, G.; Brugger, P. 1989: In vitro cardiac effects and antiarrhythmic properties of guanfacine Arzneimittel-Forschung 39(4): 450-454
Samvelian, V.M.; L'vov, M.V. 1970: Antiarrhythmic properties of fubromegan on different models of experimental cardiac arrhythmia Farmakologiia i Toksikologiia 33(3): 309-313
Sapa, J. 2010: Antiarrhythmic activity of novel S-enantiomers of pyrrolidin-2-one derivatives with adrenolytic properties Acta Poloniae Pharmaceutica 67(5): 537-542
Kohlhardt, M. 1989: Elementary properties and the interaction of single myocardial Na+ channels with antiarrhythmic drugs Arzneimittel-Forschung 39(1a): 126-129
Broustet, P.; Daubeze, J.; Giraudet, C.; Clementy, J.; Fourcade, J.P.; Choussat, A. 1974: Application anti-arrhythmic properties of amiodarone to the treatment of atrial disease Therapie 29(1): 131-136
Busch, A.E.; Netzer, T.; Ullrich, F.; Mutschler, E. 1991: Antiarrhythmic properties of benzyl-triamterene derivatives in the coronary artery ligated and reperfused rat Arzneimittel-Forschung 41(2): 125-127